All Posts By

Smartkarma Daily Briefs

Daily Brief Health Care: Hanmi Science, Novo Nordisk A/S, Siloam International Hospitals, Sigma Healthcare, Mural Oncology , Immix Biopharma Inc, Legend Biotech Corp and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Hanmi Science: NPS Sides With Mother (Chairwoman) And Daughter
  • Novo Nordisk: Is the FDA Approval of Wegovy Worth an Extra $460 Bn?
  • Siloam International Hospitals (SILO IJ) – Growth Through Intensity & Efficiency
  • Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential
  • Mural Oncology Plc (MURA) – Tuesday, Dec 26, 2023
  • Immix Biopharma – Marching towards US clinical trials for NXC-201
  • Legend Biotech Corporation: Initiation of Coverage – Can They Flourish In The Competitive CAR-T Therapy Market? – Major Drivers


Hanmi Science: NPS Sides With Mother (Chairwoman) And Daughter

By Douglas Kim

  • After the market close on 26 March, it was reported that NPS has decided it will side with Chairwoman Young-Sook Song (mother) and her daughter Ju-Hyun Lim. 
  • As a result, Chairwoman Young-Sook Song (mother) and Ju-Hyun Lim have secured 40.86% of the shares, which is slightly higher than the ownership of her two sons (38.4%). 
  • In the near term, this battle for the control of the company could have a positive impact on Hanmi Science’s share price. 

Novo Nordisk: Is the FDA Approval of Wegovy Worth an Extra $460 Bn?

By Avien Pillay

  • FDA approval of Wegovy is overvalued at approx. $460 billion. Market exaggerated the worth without proper assessment of weight loss results and risks associated with the drug.
  • Clinical trials showed a 14.9% weight loss with diet and exercise; real-world results would be lower. Impact on BMI for obese individuals won’t be significant. Long-term use is questionable.
  • Competition in the GLP-1 market is fierce. Novo Nordisk faces challenges in India and China, increased capex spending, and risks from compounding pharmacies and potential legal issues.

Siloam International Hospitals (SILO IJ) – Growth Through Intensity & Efficiency

By Angus Mackintosh

  • Siloam International Hospitals (SILO IJ) released a strong set of numbers in FY2023, with increasing inpatient admissions and treatment intensity despite a normalising environment coming out of the pandemic.
  • The average revenue per occupied bed remained significantly above peers, whilst the company continued to focus on highly complex clinical programs across cardiology, neurology, oncology, and orthopaedic surgery. 
  • Siloam International Hospitals takes a blended approach to premium, value-seeker, and BPJS patients, optimising  efficiencies around the latter. Valuations and growth stack up favourably versus its peers.

Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential

By Tina Banerjee

  • Sigma Healthcare (SIG AU)‘s proposed merger with Chemist Warehouse Group is being reviewed by Australian Competition and Consumer Commission (ACCC), with decision expected in 2H24.
  • Although Sigma is witnessing continuing momentum in its business (YTD sales are up by 6.6% YoY) and reaffirmed EBIT margin guidance, merger uncertainty overshadows the improved financial performance.
  • We think near-term positives of the company have already been priced in, thereby limited room for upside potential. Merger uncertainty will remain an overhang on the share prices.

Mural Oncology Plc (MURA) – Tuesday, Dec 26, 2023

By Value Investors Club

  • MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from Alkermes
  • Despite a rough start, it is gaining attention and has a market cap of $74 million with $16/share in cash
  • Morgan Stanley projects a trading value range estimate of $32-$63/share based on potential sales from their lead pipeline candidate; company is funded with $275 million in cash until 2025

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Immix Biopharma – Marching towards US clinical trials for NXC-201

By Edison Investment Research

Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company’s US multi-site NEXICART-2 trial assessing NXC-201 in relapsed/refractory (r/r) amyloid light chain amyloidosis (ALA). NXC-201 targets B-cell maturation antigen (BCMA) and is differentiated by its low neurotoxicity and short cytokine release syndrome (CRS) duration to date, supporting Immix’s long-term aspiration to launch the first outpatient CAR-T therapy. The NEXICART-2 study will aim to reproduce the initial results from the Phase Ib/IIa NEXICART-1 study, which reported an overall response rate (ORR) of 100% for the first 10 patients treated. Top-line data from the first 40 patients in the NEXICART-2 trial are expected in 2025, which, if positive, will likely be followed by a biologic license application, a significant milestone for the Immix. The pipeline remains engaged, with IMX-110 in Phase Ib/IIa studies for solid tumors and NXC-201 also targeting multiple myeloma (MM) and, potentially, other autoimmune indications (starting H124).


Legend Biotech Corporation: Initiation of Coverage – Can They Flourish In The Competitive CAR-T Therapy Market? – Major Drivers

By Baptista Research

  • This is our first report on biopharma player, Legend Biotech.
  • The company’s Q4 earnings call displayed a balance of positive and negative performance aspects for the company.
  • Starting with positive highlights, the outlook is promising for their lead therapy, CARVYKTI, which has received a positive opinion from the Committee for Medicinal Products for Human Use for expansion into earlier lines of treatment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Shinhan Financial, S&P/ASX 200, Bitcoin, Greentown China, Binjiang Service Group, BRP Group , Bakkt and more

By | Daily Briefs, Financials

In today’s briefing:

  • Shinhan Financial Group Placement – Another Selldown, Momentum Is Strong but Deal Is Large
  • Block Deal Sale of 3.6% Stake in Shinhan Financial by BNP Paribas
  • EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)
  • Crypto Crisp: Larry Fink vs. Gary Gensler
  • Greentown China – Earnings Flash – FY 2023 Results – Lucror Analytics
  • Binjiang (3316 HK) FY23 Results: 74% of the Market Cap in Cash, 8% Dividend Yield
  • BRP: Initiation of Coverage – 4 Pivotal Factors Driving Its Growth! – Financial Forecasts
  • Bakkt Holdings, Inc. – New CEO Comments on 4Q23 Earnings and the Way Forward


Shinhan Financial Group Placement – Another Selldown, Momentum Is Strong but Deal Is Large

By Sumeet Singh

  • BNP Paribas (BNP FP) is looking to raise around US$680m via selling 3.5% of its stake in Shinhan Financial (055550 KS).
  • This will be the fourth selldown for the stock since the start of the year. It will also be the largest one of the lot, so far.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Block Deal Sale of 3.6% Stake in Shinhan Financial by BNP Paribas

By Douglas Kim

  • After the market close on 26 March, it was announced that BNP Paribas plans to sell its 3.6% stake in Shinhan Financial in a block deal sale 18.7 million shares). 
  • The block deal sale is estimated to be about 900 billion won, which would represent one of the largest block deal sales in Korea in the past several years.
  • We have a Negative view on the Shinhan Financial Group block deal and we would not subscribe to it due to three major reasons. 

EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)

By Nico Rosti

  • The S&P/ASX 200 Index has reached a specific resistance level that often precedes a short-term pullback, when this pattern is encountered.
  • The pullback may happen next week, but this week is also a potential candidate since the 2nd week up is usually pretty weak when this pattern is encountered.
  • Hold your LONG positions and cover them to hedge. Going SHORT is probably best at the end of the week, on Friday, if the week is closing up.

Crypto Crisp: Larry Fink vs. Gary Gensler

By Mads Eberhardt

  • We are witnessing an unexpected showdown in the crypto world.
  • On one side stands Larry Fink, co-founder and CEO of BlackRock, the world’s largest asset manager.
  • On the opposite side is Gary Gensler, the chair of the U.S. Securities and Exchange Commission (SEC).

Greentown China – Earnings Flash – FY 2023 Results – Lucror Analytics

By Leonard Law, CFA

Greentown China’s FY 2023 performance was satisfactory in our view, given the above-industry sales, stable top line and acceptable (albeit reduced) gross margin. Importantly, its access to onshore financing appears healthy and liquidity is adequate. In addition, the company remains active in land acquisitions and has a good quality land bank, mostly in high-tier cities in the Yangtze River Delta.

That said, leverage remained somewhat weak. Moreover, Greentown is more exposed to a prolonged industry downturn (vs. peers such as Longfor Group and China Vanke), due to its low recurring income and outsized exposure to the property development segment. This means that the company’s contracted sales and margins are likely to remain soft despite outperforming the industry. In the meantime, Greentown will likely focus on improving operating efficiency by maintaining a high sell-through rate and fast churn for its projects.

We revise our fundamental Credit Bias to “Negative” from “Stable”, and move our trade recommendation on the GRNCH 5.95 ’24s to “Buy” from “Hold” .


Binjiang (3316 HK) FY23 Results: 74% of the Market Cap in Cash, 8% Dividend Yield

By Sameer Taneja

  • Binjiang Service Group (3316 HK) posted a 42% YoY increase in revenue and 19% YoY in profits for FY23, aided by 170% revenue growth in VAS services (24% of revenues).
  • Margin decline remains a concern, with a GPM(%) decline of 510 bps to 24.8%, with declines across all business segments. 
  • Net cash increased to 74% of market capitalization, with the company declaring a dividend of 1.37 HKD/share ( implying an 8% trailing yield). 

BRP: Initiation of Coverage – 4 Pivotal Factors Driving Its Growth! – Financial Forecasts

By Baptista Research

  • This is our first report on powersport vehicles and marine products, BRP Inc. The company’s fiscal year 2024 third quarter results conference call highlighted mixed performances across its categories of operation.
  • Revenue reached $2.5 billion, which fell short of expectations due to softer demand in international markets and a temporary slowdown at the Texas-Mexico border.
  • Although these conditions negatively impacted deliveries of its off-road vehicles and ETVs over three weeks, normalcy has been restored.

Bakkt Holdings, Inc. – New CEO Comments on 4Q23 Earnings and the Way Forward

By Water Tower Research

  • Bakkt’s new President and CEO Andy Main led the earnings call, where net revenue of $16.7 million was better than pre-announced, while the GAAP EPS loss of $0.29 was worse than our expectation of a $0.19 loss, driven by higher restructuring and goodwill write-downs.
  • While 4Q23 was pretty much old news, Main highlighted how strong tailwinds in 1Q24 have led to significant notional crypto trading volume increases.
  • He stated that, “QTD notional traded volumes have been very strong, with March QTD up over ~260% from 4Q23 versus overall market activity up ~65%.”

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: BYD, Hana Tour Service, Anta Sports Products, Bukalapak.com PT Tbk, TSE Tokyo Price Index TOPIX, Alibaba Pictures, Meituan, Porsche Automobil Holding , Brunswick Corp and more

By | Consumer, Daily Briefs

In today’s briefing:

  • BYD (1211 HK): Strong Revenue in 2023 and to Change Strategy in 2024
  • HanaTour Management Sale: Minority Shareholder Tender Offer & Price Premium Assessment
  • Anta Sports (2020 HK):  2024 High Conviction Update – Earnings Beat In 2H23
  • Bukalapak.com (BUKA IJ) – On the Cusp of Breakeven
  • Shareholder Returns Should Be Examined on a Cash Basis, Not on a Net Profit Basis
  • BABA’s Babies: They Are All Grown Up! Ali Pictures: A Blockbuster Company
  • [Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure
  • Hana Tour Service: Major Shareholders Including IMM PE Likely to Sell Their Shares
  • Preference for Deleveraging, Model Update
  • Brunswick Corporation – Initiation Of Coverage – Does It Have A Sustainable Competitive Advantage? – Major Drivers


BYD (1211 HK): Strong Revenue in 2023 and to Change Strategy in 2024

By Ming Lu

  • Total revenue increase by 42% and automobile revenue increased by 49% in 2023.
  • The gross margin improved significantly in 2023, especially in 4Q23.
  • We believe BYD will move its focus from ‘low price for sales volume’ to ‘development of new vehicle models’.

HanaTour Management Sale: Minority Shareholder Tender Offer & Price Premium Assessment

By Sanghyun Park

  • HanaTour seeks new ownership after 4 years under IMM PE. Despite COVID-19 setbacks, successful restructuring attracts attention from online travel and investment giants.
  • Market rumors hint at Yanolja and Hotels.com interest, possibly intensifying acquisition competition, leading to a higher price premium. IMM’s 16.68% stake may value at ₩250B, a 35% premium.
  • Last year’s mandatory tender offer for 50%+1 share awaits legislation. Unlikely to affect HanaTour sale. Nonetheless, potential acquirers may buy additional shares, suggesting further premium formation in share price.

Anta Sports (2020 HK):  2024 High Conviction Update – Earnings Beat In 2H23

By Steve Zhou, CFA

  • At noon time today, Anta Sports Products (2020 HK) released strong 2023 results which beat expectations. 
  • Anta currently trades at a forward PE of 18x based on estimated 2024 earnings (assuming a conservative 15% yoy growth in 2024 earnings). 
  • I expect the company’s net profit to grow 15-20% CAGR in 2024-2026.  Anta’s historical forward PE is around 24x since 2017. 

Bukalapak.com (BUKA IJ) – On the Cusp of Breakeven

By Angus Mackintosh

  • Bukalapak.com (BUKA IJ) booked a slightly weaker finish to the year than expected with a slowdown in revenue growth in 4Q2023 and a miss on adjusted EBITDA breakeven.
  • The key reason was a thinning out of non-performing specialty businesses which impacted short-term revenues but will improve revenues and adjusted EBITDA. as the focus shifts to higher take-rate businesses.
  • Bukalapak.com PT Tbk (BUKA IJ) is guiding for +15-20% revenue growth and positive adjusted EBITDA in 2024 with execution on this being paramount. Valuations remain attractive.

Shareholder Returns Should Be Examined on a Cash Basis, Not on a Net Profit Basis

By Aki Matsumoto

  • The pace of share repurchases in 2023 (+1.4%, YoY) is not sufficient compared to the increase in corporate profits, and there is much room for reconsideration of cash allocations.
  • In Japan, where many manufacturers keep CapEx within the depreciation, it’s more important to verify whether shareholder return is appropriate on a cash basis rather than a net income basis.
  • Companies that fail to formulate measures to generate ROE that exceeds the cost of capital in accordance with TSE requests are not able to achieve an appropriate cash allocation.

BABA’s Babies: They Are All Grown Up! Ali Pictures: A Blockbuster Company

By David Mudd

  • Alibaba Pictures (1060 HK) is expanding rapidly into complimentary areas such as online ticketing of cinema and live events with the recent acquisition of  Damai.cn from parent Alibaba.
  • Alibaba Group Holding (9988 HK) is considering injecting other media platform assets like Youku  to realize synergies among its portfolio of companies.
  • Ali Pictures (Alipics) legacy film production business continues to expand globally with its American film production company, Amblin which is a partnership with Steven Spielberg.

[Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure

By Ying Pan

  • Meituan reported C4Q23 revenue beat our estimate/consensus by 0.7%/1.4%; operating profit beat our estimate/consensus by 37.3%/48.6%, mainly due to order volume surprise, which is unsustainable in our view.
  • However, we think Meituan’s near term pressures did not change: (1) core biz OPM drop due to rising low-price orders and subsidies; (2) resuming competition from Eleme/Douyin/PDD
  • We maintain the stock as SELL rating but raise TP by HK$13 to HK$70 to factor in the loss cutting commitment in the community group buying biz.

Hana Tour Service: Major Shareholders Including IMM PE Likely to Sell Their Shares

By Douglas Kim

  • Hana Tour Service (039130 KS), the number one travel platform in Korea,  announced that IMM PE (controlling shareholder of the company) is planning to sell its controlling stake. 
  • The total stake in the company that is up for sale could rise to 27.78%, including stakes held by Hana Tour founder Park Sang-hwan and co-founder Kwon Hee-seok. 
  • Potential buyers of the controlling stake in Hana Tour include Yanolja, Hotels.com, Booking.com, and Trip.com.

Preference for Deleveraging, Model Update

By Jesus Rodriguez Aguilar

  • Net debt improved by around €1 billion to c. €5.8 billion. Prioritising deleveraging and allocations to new venture investments over dividends seem to have a negative impact on valuation.
  • Porsche SE is viewed as a holding company of Volkswagen Group, which should warrant a discount of 15%-25% on the stock, instead of the massive 44.6% discount to NAV.
  • Assuming a typical company holding discount of 15-25% range, the current share price indicates Porsche SE is liable for the whole c. €6.5 billion legal claims.

Brunswick Corporation – Initiation Of Coverage – Does It Have A Sustainable Competitive Advantage? – Major Drivers

By Baptista Research

  • This is our first report on recreation products manufacturer, Brunswick Corporation.
  • Despite market headwinds, the company reports another successful year, claiming to have accomplished the second highest sales and adjusted earnings per share in its existence.
  • In particular, Brunswick stresses the progress of its strategic initiatives, continued market share increases, cost control, the launch of new products, and an enhancement in operational efficiency.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Valeura Energy Inc and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Valeura Energy (TSX: VLE): Additional exploration upside. Lower decommissioning liabilities


Valeura Energy (TSX: VLE): Additional exploration upside. Lower decommissioning liabilities

By Auctus Advisors

  • FY23 production, YE23 net cash and YE23 reserves and resources had been reported previously.
  • The FY24 production guidance of 21.5-24.5 mbbl/d with US$205-235 mm opex and US$135-155 mm capex has been re-iterated.
  • Current production continues to be high, with average production for the first half of March of ~23,000 bbl/d, including ~7.9 mbbl/d for Jasmine, 7.2 mbbl/d for Nong Yao, 2.9 bbl/d for Manora and 4.9 mbbl/d for Wassana.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: S&P/ASX 200, Sigma Healthcare and more

By | Australia, Daily Briefs

In today’s briefing:

  • EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)
  • Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential


EQD | S&P/ASX200 Pullback In Sight (This Week or the Next)

By Nico Rosti

  • The S&P/ASX 200 Index has reached a specific resistance level that often precedes a short-term pullback, when this pattern is encountered.
  • The pullback may happen next week, but this week is also a potential candidate since the 2nd week up is usually pretty weak when this pattern is encountered.
  • Hold your LONG positions and cover them to hedge. Going SHORT is probably best at the end of the week, on Friday, if the week is closing up.

Sigma Healthcare (SIG AU): Merger Uncertainty To Limit Upside Potential

By Tina Banerjee

  • Sigma Healthcare (SIG AU)‘s proposed merger with Chemist Warehouse Group is being reviewed by Australian Competition and Consumer Commission (ACCC), with decision expected in 2H24.
  • Although Sigma is witnessing continuing momentum in its business (YTD sales are up by 6.6% YoY) and reaffirmed EBIT margin guidance, merger uncertainty overshadows the improved financial performance.
  • We think near-term positives of the company have already been priced in, thereby limited room for upside potential. Merger uncertainty will remain an overhang on the share prices.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Shinhan Financial, Hana Tour Service, Hanmi Science, WCP and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Shinhan Financial Group Placement – Another Selldown, Momentum Is Strong but Deal Is Large
  • Block Deal Sale of 3.6% Stake in Shinhan Financial by BNP Paribas
  • HanaTour Management Sale: Minority Shareholder Tender Offer & Price Premium Assessment
  • Hanmi Science: NPS Sides With Mother (Chairwoman) And Daughter
  • Hana Tour Service: Major Shareholders Including IMM PE Likely to Sell Their Shares
  • W-Scope IPO Lock-Up – Part of the Parent’s Stake Will Be Freed, but It’s Been Adding Instead


Shinhan Financial Group Placement – Another Selldown, Momentum Is Strong but Deal Is Large

By Sumeet Singh

  • BNP Paribas (BNP FP) is looking to raise around US$680m via selling 3.5% of its stake in Shinhan Financial (055550 KS).
  • This will be the fourth selldown for the stock since the start of the year. It will also be the largest one of the lot, so far.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Block Deal Sale of 3.6% Stake in Shinhan Financial by BNP Paribas

By Douglas Kim

  • After the market close on 26 March, it was announced that BNP Paribas plans to sell its 3.6% stake in Shinhan Financial in a block deal sale 18.7 million shares). 
  • The block deal sale is estimated to be about 900 billion won, which would represent one of the largest block deal sales in Korea in the past several years.
  • We have a Negative view on the Shinhan Financial Group block deal and we would not subscribe to it due to three major reasons. 

HanaTour Management Sale: Minority Shareholder Tender Offer & Price Premium Assessment

By Sanghyun Park

  • HanaTour seeks new ownership after 4 years under IMM PE. Despite COVID-19 setbacks, successful restructuring attracts attention from online travel and investment giants.
  • Market rumors hint at Yanolja and Hotels.com interest, possibly intensifying acquisition competition, leading to a higher price premium. IMM’s 16.68% stake may value at ₩250B, a 35% premium.
  • Last year’s mandatory tender offer for 50%+1 share awaits legislation. Unlikely to affect HanaTour sale. Nonetheless, potential acquirers may buy additional shares, suggesting further premium formation in share price.

Hanmi Science: NPS Sides With Mother (Chairwoman) And Daughter

By Douglas Kim

  • After the market close on 26 March, it was reported that NPS has decided it will side with Chairwoman Young-Sook Song (mother) and her daughter Ju-Hyun Lim. 
  • As a result, Chairwoman Young-Sook Song (mother) and Ju-Hyun Lim have secured 40.86% of the shares, which is slightly higher than the ownership of her two sons (38.4%). 
  • In the near term, this battle for the control of the company could have a positive impact on Hanmi Science’s share price. 

Hana Tour Service: Major Shareholders Including IMM PE Likely to Sell Their Shares

By Douglas Kim

  • Hana Tour Service (039130 KS), the number one travel platform in Korea,  announced that IMM PE (controlling shareholder of the company) is planning to sell its controlling stake. 
  • The total stake in the company that is up for sale could rise to 27.78%, including stakes held by Hana Tour founder Park Sang-hwan and co-founder Kwon Hee-seok. 
  • Potential buyers of the controlling stake in Hana Tour include Yanolja, Hotels.com, Booking.com, and Trip.com.

W-Scope IPO Lock-Up – Part of the Parent’s Stake Will Be Freed, but It’s Been Adding Instead

By Sumeet Singh

  • WCP raised around US$314m via selling a mix of primary and secondary shares in its Korean IPO. The lockup on some of its parent’s stake will expire soon.
  • WCP designs, manufactures, and sells separators, which are one of the four core materials for secondary Lithium-ion batteries.
  • In this note, we will talk about the lock-up dynamics and updates since our last note.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Beng Kuang Marine, Isoteam Ltd and more

By | Daily Briefs, Singapore

In today’s briefing:

  • 80 Singapore Stocks that Added Gains or Maintained Returns in 1Q24
  • kopi-C with ISOTeam’s CEO: “Why I’m investing in both drones and professional development”


80 Singapore Stocks that Added Gains or Maintained Returns in 1Q24

By Geoff Howie

  • Of the 200+ Singapore-listed stocks that booked positive total returns in 2023, more than 80 stocks have added gains or maintained their positive total return in 1Q24 (as at 25 March).
  • Seven of these 10 stocks maintain a single digit P/E ratio with three of the seven stocks also trading below book value.
  • According to the SGX Stock Screener, Beng Kuang Marine maintains the next highest ROE of the 80+ stocks at 43.7%, with a P/E ratio of 4.5x as of 25 March.

kopi-C with ISOTeam’s CEO: “Why I’m investing in both drones and professional development”

By Geoff Howie

  • kopi-C with ISOTeam’s CEO: “I’m investing in both drones and professional development” For people who live in Housing Development Board (HDB) flats in Singapore, drones may soon become a common sight.
  • ISOTeam, which specialises in maintaining and upgrading buildings, has been using drones for façade inspections since 2021.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Bukalapak.com PT Tbk, Siloam International Hospitals, MGM China Holdings, Pintar Pemenang Asia PT and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Bukalapak.com (BUKA IJ) – On the Cusp of Breakeven
  • Siloam International Hospitals (SILO IJ) – Growth Through Intensity & Efficiency
  • Morning Views Asia: MGM China Holdings, Pakuwon Jati
  • PINTAR Gets US$3M in Pre-Series A Funding Round to Help Workers Get Out of the Middle Income Trap


Bukalapak.com (BUKA IJ) – On the Cusp of Breakeven

By Angus Mackintosh

  • Bukalapak.com (BUKA IJ) booked a slightly weaker finish to the year than expected with a slowdown in revenue growth in 4Q2023 and a miss on adjusted EBITDA breakeven.
  • The key reason was a thinning out of non-performing specialty businesses which impacted short-term revenues but will improve revenues and adjusted EBITDA. as the focus shifts to higher take-rate businesses.
  • Bukalapak.com PT Tbk (BUKA IJ) is guiding for +15-20% revenue growth and positive adjusted EBITDA in 2024 with execution on this being paramount. Valuations remain attractive.

Siloam International Hospitals (SILO IJ) – Growth Through Intensity & Efficiency

By Angus Mackintosh

  • Siloam International Hospitals (SILO IJ) released a strong set of numbers in FY2023, with increasing inpatient admissions and treatment intensity despite a normalising environment coming out of the pandemic.
  • The average revenue per occupied bed remained significantly above peers, whilst the company continued to focus on highly complex clinical programs across cardiology, neurology, oncology, and orthopaedic surgery. 
  • Siloam International Hospitals takes a blended approach to premium, value-seeker, and BPJS patients, optimising  efficiencies around the latter. Valuations and growth stack up favourably versus its peers.

Morning Views Asia: MGM China Holdings, Pakuwon Jati

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


PINTAR Gets US$3M in Pre-Series A Funding Round to Help Workers Get Out of the Middle Income Trap

By e27

  • Indonesian edutech platform PINTAR announced that it has raised US$3 million in Pre-Series A funding led by Havez Capital with the participation of SIG Venture Capital.
  • In a press statement, the startup said that the funding marks a new chapter for PINTAR in achieving its mission of helping Indonesian workers to upskill and get out of the middle-income trap with the help of technology.
  • Starting in 2013 under the HarukaEdu and Pintaria brands, PINTAR offers various online education programmes for college and university levels, enterprise training programmes for employees, boot camp certification and masterclasses.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Micron Technology, Bitcoin, Oracle Corp, Charter Communications , Brunswick Corp, US Treasury (10 Yr Generic), Harley Davidson, BRP Group , Boyd Gaming, International Game Technology Ordinary Shares and more

By | Daily Briefs, United States

In today’s briefing:

  • Micron’s Earnings and Broadcom’s Accelerators
  • Crypto Crisp: Larry Fink vs. Gary Gensler
  • Oracle Corporation: How Long Will The Cloud Revenue Growth Last? – Major Drivers
  • Charter Communications Inc (CHTR) – Tuesday, Dec 26, 2023
  • Brunswick Corporation – Initiation Of Coverage – Does It Have A Sustainable Competitive Advantage? – Major Drivers
  • Downgrading Real Estate to Underweight; Bullish Outlook Intact; Broadening Participation
  • Harley-Davidson Inc.: Initiation of Coverage – An Analysis Of Its Competitive Advantage
  • BRP: Initiation of Coverage – 4 Pivotal Factors Driving Its Growth! – Financial Forecasts
  • Boyd Gaming Corporation – 4 Major Growth Drivers & 3 Challenges In Front Of This Company That You Must Know! – Financial Forecasts
  • International Game Technology: Initiation of Coverage – Is The Immense Growth In Gaming & Digital Segments A Valid Reason For A Bullish Rating? – Major Drivers


Micron’s Earnings and Broadcom’s Accelerators

By Douglas O’Laughlin

  • I wrote about this in my recent post about HBM, and it seems almost everything I talked about became true. HBM is going to bail out the memory markets meaningfully.
  • Let’s talk about earnings, but I was hoping you could keep this post in mind while I discuss Micron.
  • These are the kinds of beats we start to see when the cycle turns. Now, the stocks have begun to anticipate this, but given the pricing dynamics of HBM, I feel very confident in Micron’s ability to hit a new cycle high in profitability.


Crypto Crisp: Larry Fink vs. Gary Gensler

By Mads Eberhardt

  • We are witnessing an unexpected showdown in the crypto world.
  • On one side stands Larry Fink, co-founder and CEO of BlackRock, the world’s largest asset manager.
  • On the opposite side is Gary Gensler, the chair of the U.S. Securities and Exchange Commission (SEC).

Oracle Corporation: How Long Will The Cloud Revenue Growth Last? – Major Drivers

By Baptista Research

  • Oracle Corporation had a strong performance in its third-quarter fiscal year 2024, with revenue in-line with expectations and EPS $0.02 above the high-end guidance.
  • However, both potential future performance and inherent risks were noted, which investors should closely observe.
  • A significant part of the discussion was centered on Oracle Cloud Infrastructure (OCI), tagged as the primary driver for the company’s overall revenue acceleration.

Charter Communications Inc (CHTR) – Tuesday, Dec 26, 2023

By Value Investors Club

  • Charter Communications is contending with a narrowing competitive advantage in the cable industry due to the entrance of new rivals like fiber overbuilders and fixed wireless providers.
  • The company must make ongoing capital investments to stay competitive, despite uncertain returns on these investments.
  • Charter’s aggressive capital allocation approach, motivated by management incentives, is raising doubts about the company’s investment potential and future outlook.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Brunswick Corporation – Initiation Of Coverage – Does It Have A Sustainable Competitive Advantage? – Major Drivers

By Baptista Research

  • This is our first report on recreation products manufacturer, Brunswick Corporation.
  • Despite market headwinds, the company reports another successful year, claiming to have accomplished the second highest sales and adjusted earnings per share in its existence.
  • In particular, Brunswick stresses the progress of its strategic initiatives, continued market share increases, cost control, the launch of new products, and an enhancement in operational efficiency.

Downgrading Real Estate to Underweight; Bullish Outlook Intact; Broadening Participation

By Joe Jasper

  • Our bullish outlook initiated on November 7, 2023 remains intact; this intermediate-to-long-term outlook is likely to stay in place as long as 4800 support holds on the SPX (7-10% downside).
  • To be clear, we aren’t calling for a pullback to 4800; we view it as a worst-case scenario for the S&P 500, and we want to be prepared for anything.
  • Shorter-Term, we remain bullish on the S&P 500 and Nasdaq 100 (QQQ) as they both refuse to close below their 20-day MAs for more than 2-3 consecutive days.

Harley-Davidson Inc.: Initiation of Coverage – An Analysis Of Its Competitive Advantage

By Baptista Research

  • This is our first report on motorcycle giant, Harley-Davidson.
  • The company has demonstrated progress in key aspects of its strategic plan, the Hardwire strategy, despite challenges due to high-interest-rate environment and consumer confidence and affordability concerns impacting premium discretionary products.
  • The company’s focus on its profitable categories, innovation, and enhancing the customer experience has enhanced its business and contributed to long-term value creation.

BRP: Initiation of Coverage – 4 Pivotal Factors Driving Its Growth! – Financial Forecasts

By Baptista Research

  • This is our first report on powersport vehicles and marine products, BRP Inc. The company’s fiscal year 2024 third quarter results conference call highlighted mixed performances across its categories of operation.
  • Revenue reached $2.5 billion, which fell short of expectations due to softer demand in international markets and a temporary slowdown at the Texas-Mexico border.
  • Although these conditions negatively impacted deliveries of its off-road vehicles and ETVs over three weeks, normalcy has been restored.

Boyd Gaming Corporation – 4 Major Growth Drivers & 3 Challenges In Front Of This Company That You Must Know! – Financial Forecasts

By Baptista Research

  • This is our first report on Boyd Gaming Corporation.
  • The company’s fourth-quarter earnings call wrapped up another successful year for the company.
  • Throughout 2023, they maintained strong performances and achieved record revenues and EBITDAR. This success is largely thanks to a diverse portfolio which includes strong growth from their online and managed businesses.

International Game Technology: Initiation of Coverage – Is The Immense Growth In Gaming & Digital Segments A Valid Reason For A Bullish Rating? – Major Drivers

By Baptista Research

  • This is our first report on gaming technology player, International Game Technology PLC (IGT).
  • The company ended fiscal year 2023 with an impressive set of accomplishments, with their Q4 operating income growing 11% and significant free cash flow generation.
  • This enabled them to meet their fiscal year 2023 financial goals which were raised twice during the year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: BYD, Anta Sports Products, CIMC Vehicle Group Co Ltd, Tencent, Alibaba Pictures, Sinotrans, Meituan, Greentown China, CIMC Enric Holdings, Binjiang Service Group and more

By | China, Daily Briefs

In today’s briefing:

  • BYD (1211 HK): Strong Revenue in 2023 and to Change Strategy in 2024
  • Anta Sports (2020 HK):  2024 High Conviction Update – Earnings Beat In 2H23
  • CIMC Vehicles (1839 HK): Vote on 18 April as Uncertainty Lingers on the 90% Acceptance Threshold
  • [Tencent (700 HK, BUY, TP HK$351) TP Change]: Improvement of Earning Quality Should Be Sustainable
  • BABA’s Babies: They Are All Grown Up! Ali Pictures: A Blockbuster Company
  • Sinotrans (598. HK) Continues to Deliver
  • [Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure
  • Greentown China – Earnings Flash – FY 2023 Results – Lucror Analytics
  • CIMC Enric (3899 HK): Positive Takeaways from Post-Result Call
  • Binjiang (3316 HK) FY23 Results: 74% of the Market Cap in Cash, 8% Dividend Yield


BYD (1211 HK): Strong Revenue in 2023 and to Change Strategy in 2024

By Ming Lu

  • Total revenue increase by 42% and automobile revenue increased by 49% in 2023.
  • The gross margin improved significantly in 2023, especially in 4Q23.
  • We believe BYD will move its focus from ‘low price for sales volume’ to ‘development of new vehicle models’.

Anta Sports (2020 HK):  2024 High Conviction Update – Earnings Beat In 2H23

By Steve Zhou, CFA

  • At noon time today, Anta Sports Products (2020 HK) released strong 2023 results which beat expectations. 
  • Anta currently trades at a forward PE of 18x based on estimated 2024 earnings (assuming a conservative 15% yoy growth in 2024 earnings). 
  • I expect the company’s net profit to grow 15-20% CAGR in 2024-2026.  Anta’s historical forward PE is around 24x since 2017. 

CIMC Vehicles (1839 HK): Vote on 18 April as Uncertainty Lingers on the 90% Acceptance Threshold

By Arun George

  • CIMC Vehicle Group Co Ltd (1839 HK) has despatched the offer document, and the H Share HK$7.50 offer is open. The H Shareholders class vote is on 18 April.  
  • The key condition is approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders rejection) along with a 90% minimum acceptance condition.  
  • The de-rating of peers and ongoing US investigation favours meeting the 90% threshold. However, the dire minority AGM/EGM participation rates suggest that retail apathy may derail the offer. 

[Tencent (700 HK, BUY, TP HK$351) TP Change]: Improvement of Earning Quality Should Be Sustainable

By Ying Pan

  • Tencent reported C4Q23 revenue, IFRS operating profit, and non-IFRS net income in-line with our estimates and in-line with consensus, with non-game revenues exceeding while game revenue missing expectations;
  • We believe the shift from game to non-game should enhance Tencent multiples but the market might have concerns on the sustainability of this change. 
  • We believe this change is sustainable with game revenue reaccelerating and non-game revenue continues to gain weight. We cut TP by 3% to reflect slow game recovery in C1H24.

BABA’s Babies: They Are All Grown Up! Ali Pictures: A Blockbuster Company

By David Mudd

  • Alibaba Pictures (1060 HK) is expanding rapidly into complimentary areas such as online ticketing of cinema and live events with the recent acquisition of  Damai.cn from parent Alibaba.
  • Alibaba Group Holding (9988 HK) is considering injecting other media platform assets like Youku  to realize synergies among its portfolio of companies.
  • Ali Pictures (Alipics) legacy film production business continues to expand globally with its American film production company, Amblin which is a partnership with Steven Spielberg.

Sinotrans (598. HK) Continues to Deliver

By Rikki Malik

  • Cost and business optimisations lead to increased profits as revenues drop due to freight rate declines
  • Successfully pivoting by geography as the global trading environment changes
  • The company increases its dividend payout in a sign of confidence for the future

[Meituan (3690 HK, SELL, TP HK$70) TP Change]: Margin Reflects Persistent Competitive Pressure

By Ying Pan

  • Meituan reported C4Q23 revenue beat our estimate/consensus by 0.7%/1.4%; operating profit beat our estimate/consensus by 37.3%/48.6%, mainly due to order volume surprise, which is unsustainable in our view.
  • However, we think Meituan’s near term pressures did not change: (1) core biz OPM drop due to rising low-price orders and subsidies; (2) resuming competition from Eleme/Douyin/PDD
  • We maintain the stock as SELL rating but raise TP by HK$13 to HK$70 to factor in the loss cutting commitment in the community group buying biz.

Greentown China – Earnings Flash – FY 2023 Results – Lucror Analytics

By Leonard Law, CFA

Greentown China’s FY 2023 performance was satisfactory in our view, given the above-industry sales, stable top line and acceptable (albeit reduced) gross margin. Importantly, its access to onshore financing appears healthy and liquidity is adequate. In addition, the company remains active in land acquisitions and has a good quality land bank, mostly in high-tier cities in the Yangtze River Delta.

That said, leverage remained somewhat weak. Moreover, Greentown is more exposed to a prolonged industry downturn (vs. peers such as Longfor Group and China Vanke), due to its low recurring income and outsized exposure to the property development segment. This means that the company’s contracted sales and margins are likely to remain soft despite outperforming the industry. In the meantime, Greentown will likely focus on improving operating efficiency by maintaining a high sell-through rate and fast churn for its projects.

We revise our fundamental Credit Bias to “Negative” from “Stable”, and move our trade recommendation on the GRNCH 5.95 ’24s to “Buy” from “Hold” .


CIMC Enric (3899 HK): Positive Takeaways from Post-Result Call

By Osbert Tang, CFA

  • Despite weaker 2H23 results, CIMC Enric Holdings (3899 HK) guided for solid recovery in FY24. Order backlogs reached Rmb22.9bn, which almost equals the full-year revenue.
  • Clean energy segment will be supported by vessel demand, hydrogen orders, and Angang Steel project contribution. Chemical and environmental segment should rebound in 2H24.
  • Liquid food spin-off is in process and it has won several domestic whiskey projects. As net cash equals 13% of share price, payout will be maintained at 50% (FY22: 40%). 

Binjiang (3316 HK) FY23 Results: 74% of the Market Cap in Cash, 8% Dividend Yield

By Sameer Taneja

  • Binjiang Service Group (3316 HK) posted a 42% YoY increase in revenue and 19% YoY in profits for FY23, aided by 170% revenue growth in VAS services (24% of revenues).
  • Margin decline remains a concern, with a GPM(%) decline of 510 bps to 24.8%, with declines across all business segments. 
  • Net cash increased to 74% of market capitalization, with the company declaring a dividend of 1.37 HKD/share ( implying an 8% trailing yield). 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars